Skip to main content

Polypharmacy and Drug-Drug Interactions: Methadone

  • Chapter
  • First Online:
Challenging Cases and Complication Management in Pain Medicine

Abstract

Methadone is a potent opioid analgesic that is available in a racemic mixture of l-isomer, carrying the majority of opioid properties, and d-isomer, primarily related to NMDA receptor antagonist activity. Methadone is metabolized in the liver via CYP3A4 and, to a lesser extent, CYP2B6, CYP2D6, and CYP1A2. As a consequence this medication may have significant interactions with drugs that share the same metabolic pathway, sometimes contributing to increase of the toxic side effects of the methadone. QTc interval increase and significant sedation and respiratory depression are just a few of the devastating adverse events associated with methadone that account for the many reported deaths in recent years.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gaertner J, Voltz R, Ostgathe C. Methadone: a closer look at the controversy. J Pain Symptom Manag. 2008;36(2):e4–6.

    Article  Google Scholar 

  2. Gourlay GK, Cherry DA, Cousins MJ. A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer. Pain. 1986;25:297–312.

    Article  CAS  PubMed  Google Scholar 

  3. Bruera E, Sweeney C. Methadone use in cancer patients: a review. J Palliat Med. 2002;5(1):127–38.

    Article  PubMed  Google Scholar 

  4. Ettinger DS, Vitale PJ, Trump DL. Important clinical pharmacologic considerations in the use of methadone in cancer patients. Cancer Treat Rep. 1979;63:457–9.

    CAS  PubMed  Google Scholar 

  5. Garrido MJ, Aguirre C, Troconiz IF, et al. Alpha 1-acid glycoprotein (AAG) and serum protein binding of methadone in heroin addicts with abstinence syndrome. Int J Clin Pharmacol Ther. 2000;38(1):35–40.

    Article  CAS  PubMed  Google Scholar 

  6. Baumann P, Tinguely D, Schopf J. Increase of alpha 1-acid glycoprotein after treatment with amitriptyline. Br J Clin Pharmacol. 1982;14:102–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Sullivan HR, Smits SE, Due SL, et al. Metabolism of d-methadone: isolation and identification of analgesically active metabolites. Life Sci. 1972;11:1093–104.

    Article  CAS  Google Scholar 

  8. Lepakhin VK. World Health Organization Web site. Safety of medicines: a guide to detecting and reporting adverse drug reactions. 2002. http://whqlibdoc.who.int/hq/2002/WHO_EDM_QSM_2002.2.pdf. Accessed 14 Nov 2015.

  9. Shields LB, Hunsaker JC III, Corey TS, Ward MK, Stewart D. Methadone toxicity fatalities: a review of medical examiner cases in a large metropolitan area. J Forensic Sci. 2007;52:1389–95.

    Article  PubMed  Google Scholar 

  10. Webster LR, Cochella S, Dasgupta N, et al. An analysis of root causes for opioid-related overdose deaths in the United States. Pain Med. 2011;12:S26–35.

    Article  PubMed  Google Scholar 

  11. Crowther NR, Holbrook AM, Kenwright R, Kenwright M. Drug interactions among commonly used medications. Can Fam Physician. 1997;43:1972–81.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Stimmel B, Lipski J, Swartz M, Donoso E. Electrocardiographic changes in heroin, methadone and multiple drug abuse: a postulated mechanism of sudden death in narcotic addicts. Proc Natl Conf Methadone Treat. 1973;1:706–10.

    CAS  PubMed  Google Scholar 

  13. Krantz MJ, Lewkowiez L, et al. Torsades de Pointes with very-high-dose methadone. Ann Intern Med. 2002;137(6):501–4.

    Article  CAS  PubMed  Google Scholar 

  14. Roden DM. Drug-induced prolongation of the QT interval. NEJM. 2004;350:1013–22.

    Article  CAS  PubMed  Google Scholar 

  15. Kornick CA, Kilborn MJ, Santiago-Palma J, et al. QTc interval prolongation associated with intravenous methadone. Pain. 2003;105:499–506.

    Article  CAS  PubMed  Google Scholar 

  16. Soyka LF, Wirtz C, Spangenberg RB. Clinical safety profile of sotalol in patients with arrhythmias. Am J Cardiol. 1990;65(2):74A–81A.

    Article  CAS  PubMed  Google Scholar 

  17. Chou R, Weimer MB, Dana T. Methadone overdose and cardiac arrhythmia potential: findings from a review of the evidence for an American Pain Society and College on Problems of Drug Dependence clinical practice guideline. J Pain. 2014;15(4):338–65.

    Article  CAS  PubMed  Google Scholar 

  18. Baxter LE Sr, Campbell A, DeShields M, et al. Safe methadone induction and stabilization. J Addict Med. 2013;7:377–86.

    Article  CAS  PubMed  Google Scholar 

  19. Perkins NA, Murphy JE, Malone DC, Armstrong EP. Performance of drug-drug interaction software for personal digital assistants. Ann Pharmacother. 2006;40(5):850–5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David M. Dickerson M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Knoebel, R.W., Dickerson, D.M. (2018). Polypharmacy and Drug-Drug Interactions: Methadone. In: Anitescu, M., Benzon, H., Wallace, M. (eds) Challenging Cases and Complication Management in Pain Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-60072-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-60072-7_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-60070-3

  • Online ISBN: 978-3-319-60072-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics